Huber G
Universitäts-Nervenklinik, Bonn.
Fortschr Neurol Psychiatr. 2001 Sep;69 Suppl 2:S86-91. doi: 10.1055/s-2001-16536.
The paper gives reasons for the view that psychopathology has to be not only the fundamental method for clinical psychiatry, but also an essential prerequisite for a rational therapy of schizophrenia and related disorders. Because schizophrenic patients present very different types of psychopathological cross-sectional syndromes, the choice of a distinct neuroleptic or antidepressant compound and their dosage has to be guided along the psychopathological target syndrome. The clinical-therapeutical effects of neuroleptics and antidepressants are above all symptom- (Freyhan) or syndrome-directed. The differentiation of positive and negative symptoms, acute and chronic or residual schizophrenia, or of the prodromal symptoms according to contemporary approaches seems to be not sufficient for the early detection of psychopathological predictors of an impending psychosis and the special indication and choice of a distinct drug and dosing strategy. This is valid for maintenance treatment of patients in remission, for early intervention in the prodromal stages before the first and later psychotic episodes and in preventing relapses. Relapse rates can be reduced by a low dose maintenance therapy with basic symptom oriented early adaptation of the dosage in the prodromes before psychotic remanifestations. Some presuppositions of an effective psychopharmacological and psychological therapy in view of clinical psychopathology (K. Schneider) and the "phenomenological attitude" (K. Jaspers) are outlined. A necessary condition for the secondary as well as for the primary prevention of psychotic episodes is the detailed knowledge of the interindividual different dynamic and cognitive basic symptoms, defined in the Bonn Scale BSABS, that are experiential in kind and not identical with the negative and behavioral "Prodromal and Residual Symptoms" of DSM and ICD-10. The early detection and preventive intervention of schizophrenic psychoses is most likely possible by means of a subtle, descriptive-analytical phenomenology and psychopathology. Also "chronic" patients beyond acute psychoses, e. g. those with persisting pure residues, characterized not by true negative, but by basic symptoms, often respond to distinct atypical neuroleptics and/or antidepressants. The knowledge of the prodromal symptoms and the coping strategies, frequently developed by the patients themselves, is an essential component of a basic symptom oriented psychoeducational concept.
本文阐述了为何认为精神病理学不仅应是临床精神病学的基本方法,而且是合理治疗精神分裂症及相关障碍的必要前提。由于精神分裂症患者呈现出非常不同类型的精神病理学横断面综合征,选择特定的抗精神病药或抗抑郁药及其剂量必须以精神病理学目标综合征为指导。抗精神病药和抗抑郁药的临床治疗效果首先是针对症状(弗雷汉)或综合征的。根据当代方法区分阳性和阴性症状、急性和慢性或残留精神分裂症,或前驱症状,似乎不足以早期发现即将发生精神病的精神病理学预测因素以及特定药物和给药策略的特殊指征和选择。这适用于缓解期患者的维持治疗、在首次及后续精神病发作前的前驱期进行早期干预以及预防复发。通过低剂量维持治疗,在精神病复发前的前驱期根据基本症状早期调整剂量,可以降低复发率。本文概述了鉴于临床精神病理学(K. 施奈德)和“现象学态度”(K. 雅斯贝尔斯)进行有效心理药物治疗和心理治疗的一些前提条件。二级预防以及一级预防精神病发作的必要条件是详细了解个体间不同的动态和认知基本症状,这些症状在波恩量表BSABS中有所定义,它们本质上是体验性的,与DSM和ICD - 10中的阴性和行为“前驱和残留症状”不同。通过细致的描述性 - 分析性现象学和精神病理学,最有可能早期发现和预防性干预精神分裂症性精神病。同样,急性精神病之外的“慢性”患者,例如那些具有持续纯粹残留症状的患者,其特征不是真正的阴性症状,而是基本症状,通常对特定的非典型抗精神病药和/或抗抑郁药有反应。了解前驱症状以及患者自身经常制定的应对策略,是基本症状导向的心理教育概念的重要组成部分。